Sequester squeezes oncology practices and their Medicare patients

Headlines about the sequester budget cuts over the last week have focused on airline delays and Federal Aviation Administration furloughs, but the impact of the cuts could be taking a much graver toll on Medicare patients with cancer.

Clinics across the U.S. have had to turn away some Medicare patients as reduced funding is making it impossible to administer chemotherapy drugs, according to a Washington Post report.

The chief executive of one oncology group quoted in the article revealed his practice will have to turn away one-third of the Medicare patients, saying, “It’s a choice between seeing these patients and staying in business.”

Patients can seek care at a hospital, but clinic care is less expensive than hospital care, which means more costs to the federal government and out-of-pocket costs for patients, explained the Washington Post.

Full story below:

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup